1910
1910 is a Healthcare AI company on Brel, based in United States, founded in 2019. Verified focus: Multimodal AI Platform for Modality Agnostic Drug Discovery™.
AI in Healthcare · United States
Compare
1910 vs Aignostics
1910 and Aignostics are both classified in the Healthcare sector on Brel. 1910 is based in United States; Aignostics is based in Germany. 1910 focuses on multimodal AI Platform for Modality Agnostic Drug Discovery™.
What do you want to compare?
Aignostics
Aignostics is a Healthcare AI company on Brel, based in Germany.
AI in Healthcare · Germany
Compare intelligence across Sector Technologies Capabilities Industries served
Key differences
Sector
Same — Healthcare
Country
1910
United States
Aignostics
Germany
Founded
1910
2019
Aignostics
—
Stage
1910
Growth
Aignostics
—
Status
1910
Active
Aignostics
—
Product summary
1910
Multimodal AI Platform for Modality Agnostic Drug Discovery™
Aignostics
Aignostics Platform
Target customer
1910
—
Aignostics
Pathologists, pharmaceutical partners, and research organizations in digital pathology.
Technologies
1910
—
Aignostics
Computer Vision, Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging
Capabilities
1910
Multimodal AI Platform for Modality Agnostic Drug Discovery™
Aignostics
AI pathology and precision medicine analytics platform for research and clinical collaboration, per official materials.
Industries served
Same — AI in Healthcare
Where they overlap
Sectors
- Healthcare
Industries
- AI in Healthcare
Where they differ
Dimension
1910
Aignostics
Capabilities
Multimodal AI Platform for Modality Agnostic Drug Discovery™
AI pathology and precision medicine analytics platform for research and clinical collaboration, per official materials.
Technologies
—
Computer Vision, Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging
Overview
Attribute
1910
Aignostics
Sector
Healthcare
Healthcare
Country
United States
Germany
Founded
2019
—
Stage
Growth
—
Status
Active
—
Capabilities
Attribute
1910
Aignostics
Capabilities
Multimodal AI Platform for Modality Agnostic Drug Discovery™
AI pathology and precision medicine analytics platform for research and clinical collaboration, per official materials.
Product summary
Multimodal AI Platform for Modality Agnostic Drug Discovery™
Aignostics Platform
Target customer
—
Pathologists, pharmaceutical partners, and research organizations in digital pathology.
Technology
Attribute
1910
Aignostics
Technologies
—
Computer Vision, Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging
Industries & use cases
Attribute
1910
Aignostics
Industries served
AI in Healthcare
AI in Healthcare
Company
Attribute
1910
Aignostics
Linked products
—
Aignostics AI offering
Trust
Attribute
1910
Aignostics
Verification
verified
verified
Last reviewed
Aug 2026
Aug 2026
Sources & verification
1910
- Verification
- verified
- Last reviewed
- Aug 2026
- Profile
- Open profile
Aignostics
- Verification
- verified
- Last reviewed
- Aug 2026
- Profile
- Open profile